Correlation Between Total Bilirubin, Total Bilirubin/Albumin Ratio with Disease Activity in Patients with Rheumatoid Arthritis

References

• Conforti A, Di Cola I, Pavlych V, et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. 2021;20(2):102735. doi:10.1016/j.autrev.2020.102735
   PubMed Web of Science ®Google Scholar
• Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358(9285):903–911. doi:10.1016/S0140-6736(01)06075-5
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108. doi:10.1016/S0140-6736(10)60826-4
   PubMed Web of Science ®Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361. doi:10.1038/nature01661
   PubMed Web of Science ®Google Scholar
• Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther. 2004;6(6):265–278. doi:10.1186/ar1447
   PubMed Web of Science ®Google Scholar
• Kardeş S, Karagülle M, Durak İ, Avcı A, Karagülle MZ. Association of oxidative stress with clinical characteristics in patients with rheumatoid arthritis. Eur J Clin Invest. 2018;48(1). doi:10.1111/eci.12858
   Web of Science ®Google Scholar
• De Bandt M, Grossin M, Driss F, Pincemail J, Babin-Chevaye C, Pasquier C. Vitamin E uncouples joint destruction and clinical inflammation in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum. 2002;46(2):522–532. doi:10.1002/art.10085
   Google Scholar
• Sullivan JI, Rockey DC. Diagnosis and evaluation of hyperbilirubinemia. Curr Opin Gastroenterol. 2017;33(3):164–170. doi:10.1097/MOG.0000000000000354
   PubMed Web of Science ®Google Scholar
• Gazzin S, Vitek L, Watchko J, Shapiro SM, Tiribelli C. A novel perspective on the biology of bilirubin in health and disease. Trends Mol Med. 2016;22(9):758–768. doi:10.1016/j.molmed.2016.07.004
   Web of Science ®Google Scholar
• Jangi S, Otterbein L, Robson S. The molecular basis for the immunomodulatory activities of unconjugated bilirubin. Int J Biochem Cell Biol. 2013;45(12):2843–2851. doi:10.1016/j.biocel.2013.09.014
   PubMed Web of Science ®Google Scholar
• Wennberg RP. The blood-brain barrier and bilirubin encephalopathy. Cell Mol Neurobiol. 2000;20(1):97–109. doi:10.1023/a:1006900111744
   Web of Science ®Google Scholar
• Onder ENA, Ertan P. Fibrinogen-to-albumin ratio in familial Mediterranean fever: association with subclinical inflammation. Klin Padiatr. 2021;233(6):292–298. doi:10.1055/a-1610-9745
   Google Scholar
• Yang WM, Zhang WH, Ying HQ, et al. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: albumin to fibrinogen ratio and C-reactive protein to albumin ratio. Int Immunopharmacol. 2018;62:293–298. doi:10.1016/j.intimp.2018.07.007
   PubMed Web of Science ®Google Scholar
• Onder ENA, Cam FS, Ertan P. Relationship between C-reactive protein/albumin ratio and subclinical inflammation in patients with familial Mediterranean fever. Aktuelle Rheumatol. 2021;46(5):479–484. doi:10.1055/a-1403-2309
   Google Scholar
• Huang SS, Chan WL, Leu HB, Huang PH, Lin SJ, Chen JW. Serum bilirubin levels predict future development of metabolic syndrome in healthy middle-aged nonsmoking men. Am J Med. 2015;128(10):1138.e35–1138.e1.138E41. doi:10.1016/j.amjmed.2015.04.019
   Web of Science ®Google Scholar
• Kunutsor SK, Bakker SJL, Gansevoort RT, Chowdhury R, Dullaart RPF. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arterioscler Thromb Vasc Biol. 2015;35(3):716–724. doi:10.1161/ATVBAHA.114.304929
   PubMed Web of Science ®Google Scholar
• Leníček M, Ďuricová D, Hradsky O, et al. The relationship between serum bilirubin and Crohn’s disease. Inflamm Bowel Dis. 2014;20(3):481–487. doi:10.1097/01.MIB.0000440817.84251.98
   PubMed Web of Science ®Google Scholar
• Zhang Z, Su Q, Zhang L, Yang Z, Qiu Y, Mo W. Clinical significance of serum bilirubin in primary Sjögren syndrome patients. J Clin Lab Anal. 2020;34(3):e23090. doi:10.1002/jcla.23090
   Web of Science ®Google Scholar
• Koca TT. Clinical significance of serum bilirubin in Behçet’s disease. J Transl Intern Med. 2018;6(4):185–188. doi:10.2478/jtim-2018-0034
   Web of Science ®Google Scholar
• van Riel PLCM, Renskers L. The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(5 Suppl 101):S40–S44.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–699. doi:10.1136/annrheumdis-2019-216655
   PubMed Web of Science ®Google Scholar
• Wang Y, Sheng G, Shi L, Cheng X. Increased serum total bilirubin-albumin ratio was associated with bilirubin encephalopathy in neonates. Biosci Rep. 2020;40(1):BSR20192152. doi:10.1042/BSR20192152
   Google Scholar
• Hulzebos CV, Van Imhoff DE, Bos AF, Ahlfors CE, Verkade HJ, Dijk PH. Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants. Arch Dis Child Fetal Neonatal Ed. 2008;93(5):F384–F388. doi:10.1136/adc.2007.134056
   Web of Science ®Google Scholar
• Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043–1046. doi:10.1126/science.3029864
   PubMed Web of Science ®Google Scholar
• Temme EHM, Zhang J, Schouten EG, Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control. 2001;12(10):887–894. doi:10.1023/A:1013794407325
   PubMed Web of Science ®Google Scholar
• Zhang W, Tang Z, Shi Y, et al. Association between gamma-glutamyl transferase, total bilirubin and systemic lupus erythematosus in Chinese women. Front Immunol. 2021;12:682400. doi:10.3389/fimmu.2021.682400
   Web of Science ®Google Scholar
• Sykora T, Babal P, Mikus-Kuracinova K, et al. Hyperbilirubinemia maintained by chronic supplementation of unconjugated bilirubin improves the clinical course of experimental autoimmune arthritis. Int J Mol Sci. 2021;22(16):8662. doi:10.3390/ijms22168662
   PubMed Web of Science ®Google Scholar
• Oğul Y, Gür F, Cengiz M, Gür B, Sarı RA, Kızıltunç A. Evaluation of oxidant and intracellular anti-oxidant activity in rheumatoid arthritis patients: in vivo and in silico studies. Int Immunopharmacol. 2021;97:107654. doi:10.1016/j.intimp.2021.107654
   Web of Science ®Google Scholar
• Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol. 2003;157(4):345–354. doi:10.1093/aje/kwf205
   PubMed Web of Science ®Google Scholar
• Liao KP. Cardiovascular disease in patients with rheumatoid arthritis. Trends Cardiovasc Med. 2017;27(2):136–140. doi:10.1016/j.tcm.2016.07.006
   PubMed Web of Science ®Google Scholar
• Jansen T, Hortmann M, Oelze M, et al. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J Mol Cell Cardiol. 2010;49(2):186–195. doi:10.1016/j.yjmcc.2010.04.011
   PubMed Web of Science ®Google Scholar
• Li Y, Huang B, Ye T, Wang Y, Xia D, Qian J. Physiological concentrations of bilirubin control inflammatory response by inhibiting NF-κB and inflammasome activation. Int Immunopharmacol. 2020;84:106520. doi:10.1016/j.intimp.2020.106520
   PubMed Web of Science ®Google Scholar
• Kim DE, Lee Y, Kim MG, Lee S, Jon S, Lee SH. Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma. Biomaterials. 2017;140(2017):37–44. doi:10.1016/j.biomaterials.2017.06.014
   Google Scholar
• Wang WW, Smith DLH, Zucker SD. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology. 2004;40(2):424–433. doi:10.1002/hep.20334
   PubMed Web of Science ®Google Scholar
• Shiels RG, Hewage W, Pennell EN, et al. Biliverdin and bilirubin sulfonate inhibit monosodium urate induced sterile inflammation in the rat. Eur J Pharm Sci. 2020;155:105546. doi:10.1016/j.ejps.2020.105546
   PubMed Web of Science ®Google Scholar
• Khan NM, Poduval TB. Immunomodulatory and immunotoxic effects of bilirubin: molecular mechanisms. J Leukoc Biol. 2011;90(5):997–1015. doi:10.1189/jlb.0211070
   Web of Science ®Google Scholar
• Rola-Pleszczynski M, Hensen SA, Vincent MM, Bellanti JA. Inhibitory effects of bilirubin on cellular immune responses in man. J Pediatr. 1975;86(5):690–696. doi:10.1016/S0022-3476(75)80352-0
   Web of Science ®Google Scholar
• McInnes IB, Buckley CD, Isaacs JD. Cytokines in rheumatoid arthritis-shaping the immunological landscape. Nat Rev Rheumatol. 2016;12(1):63–68. doi:10.1038/nrrheum.2015.171
   PubMed Web of Science ®Google Scholar
• Vítek L. Bilirubin as a signaling molecule. Med Res Rev. 2020;40(4):1335–1351. doi:10.1002/med.21660
   PubMed Web of Science ®Google Scholar
• Keum H, Kim TW, Kim Y, et al. Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling. J Control Release. 2020;325:359–369. doi:10.1016/j.jconrel.2020.07.015
   PubMed Web of Science ®Google Scholar
• Kim TW, Kim Y, Jung W, et al. Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells. J Control Release. 2021;331:74–84. doi:10.1016/j.jconrel.2021.01.019
   PubMed Web of Science ®Google Scholar